ALNYLAM PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss
The total revenue of ALNY for the last quarter is 7.47 B MXN, and it's 42.91% lower compared to the previous quarter. The net income of Q4 23 is -2.34 B MXN.